Genentech, Inc. Extends Stock Repurchase Program

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, Inc. (NYSE:DNA) today announced that its Board of Directors has authorized the extension of its current stock repurchase program through June 30, 2009. The Board also amended the current repurchase program by increasing the maximum number of shares that can be repurchased to 150 million shares from 100 million shares and increasing the total value of shares that can be repurchased to $10 billion from $8 billion.
MORE ON THIS TOPIC